NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis

Publisher： Karger

E-ISSN： 2296-5262|38|5|221-229

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.5, 2015-05, pp. : 221-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention and Treatment of Chemotherapy-Induced Neutropenia with the Biosimilar Filgrastim: A Non-Interventional Observational Study of Clinical Practice Patterns

By  

Oncology Research and Treatment, Vol. 38, Iss. 4, 2015-03 ,pp. : 146-152

Karger

Access to resources Recommend Favorite

Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study

By  

Oncology Research and Treatment, Vol. 36, Iss. 3, 2013-02 ,pp. : 95-100

Karger

Access to resources Recommend Favorite

Pegfilgrastim – Rational Drug Design for the Management of Chemotherapy-Induced Neutropenia

By  

Oncology Research and Treatment, Vol. 28, Iss. 11, 2005-10 ,pp. : 595-602

Karger

Access to resources Recommend Favorite

MONITOR‐GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy‐induced/febrile neutropenia prophylaxis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 241-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study

By Fiegl Michael   Steger Günther G.   Studnicka Michael   Eisterer Wolfgang   Jaeger Christine   Willenbacher Wolfgang  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 505-515

Informa Healthcare

Access to resources Recommend Favorite